s6y
Company name or ticker
Search
Rein Therapeutics, Inc.
ARS
Annual report to security holders
Filed
Monday, June 8, 2026
Period
Dec 31, 2025
Accession number
0001193125-26-260814
Documents
ARS
ARS
On sec.gov
Filing index
All files
Complete submission text
SGML header